| NSTC Subcommittee on Open Science, Subgroup on Engagement (previously Year of Open Science Subgroup) |
Committee, Work group, Advisory group, or Task Force |
CDC |
NLM |
The White House Office of Science and Technology Policy (OSTP) launched a Year of Open Science in 2023. Throughout the year, participating agencies formed a subcommittee of the OSTP’s Subcommittee on Open Science and hosted events to promote open science, communicate the value of making research outputs open, and collaborate on activities to advance open science. A central website, open.science.gov, was created to showcase agency efforts. The Subgroup on Engagement (previously Year of Open Science Subgroup), of the Subcommittee on Open Science of the National Science and Technology Council, continues this work. open.science.gov |
| NSTC Subcommittee on Social and Behavioral Sciences |
Committee, Work group, Advisory group, or Task Force |
ACF |
NCI, OD/DPCPSI/OBSSR |
The SBS is rechartered to prioritize and expand the scope of evidence-based methods in support of Federal policymaking—particularly to advance equity. The SBS provides executive departments and agencies a forum for discussing the use of social and behavioral science methods and evidence to promote these goals in light of these disciplines' unique role in describing, understanding, and addressing societal challenges and assessing and evaluating initiatives, programs, and policies promulgated by the Federal government. The SBS will carry out short term, high-priority tasks associated with elevating best practices regarding the creation and use of social and behavioral science evidence in Federal practices and policies, and then will lay the groundwork for longer-term coordination of agency efforts related to these topics. |
| NSTC: Subcommittee on Scientific Integrity (SOSI) Implementation and Evaluation Working Group |
Committee, Work group, Advisory group, or Task Force |
ASPE, ASPE, CDC |
OD/DPCPSI/OEPR |
This working group was convened to support SOSI in implementing and assessing agency scientific integrity policies, practices and culture using the Framework’s critical metrics for assessment as outlined in the 2022 Scientific Integrity Framework Interagency Working Group report entitled A Framework for Federal Scientific Integrity Policy and Practice. |
| Nutrition Research Coordinating Committee (NRCC) |
Committee, Work group, Advisory group, or Task Force |
ACL, AHRQ, CDC, FDA, HRSA, IOS/ODPHP, OASH |
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ODS, OD/DPCPSI/ODSS, OD/DPCPSI/ONR, OD/DPCPSI/ORWH, OD/DPCPSI/OSC, OD/ECHO |
The Nutrition Research Coordinating Committee (NRCC) was established by the National Institutes of Health (NIH) Office of the Director in 1975 to improve communication and research coordination of nutrition activities within the NIH and across the federal government. Today it provides an open forum for members to discuss current and future nutrition research challenges and opportunities. The NRCC has broad representation from the NIH institutes and centers. In addition, liaisons from other federal offices and agencies also participate. The NRCC meets monthly, alternating between intra-NIH and interagency meetings. NRCC membership is open to any federal staff member interested in carrying out any trans-NIH or trans-agency nutrition research efforts. |
| OA/ABSD - HHS IAE Systems Forum (formerly DCIS User's Group Meeting) |
Meeting/ Workshop |
PSC, ARPA-H, AHRQ, CMS, HRSA, IHS |
OD/OM, OD/OM/OALM |
To open the lines of communication among the Office of Acquisition (OA), Acquisition Business Systems Division (ABSD) and its customers; this is a forum to share announcements, status reports on current and upcoming activities, and hold open discussion on the HHS Integrated Award Environment (IAE) systems. |
| Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) |
Research Initiative |
CDC |
NIAID |
This is a study of the safety, adherence, and efficacy of a fixed-dose combination of drug tenofovir/lamivudine/dolutegravir (TLD) among HIV patients, including those co-infected with tuberculosis, receiving care at PEPFAR (President’s Emergency Plan for AIDS Relief) funded sites in resource limited countries. |
| Obstetrics, Reproductive and Urologic Drugs Advisory Committee (ORUDAC) |
Committee, Work group, Advisory group, or Task Force |
FDA |
NICHD |
The Committee reviews and evaluates data on the safety and effectiveness of marketed and investigational human drug products for use in the practice of osteoporosis and metabolic bone disease, obstetrics, gynecology, urology and related specialties, and makes appropriate recommendations to the Commissioner of Food and Drugs. https://www.fda.gov/advisory-committees/human-drug-advisory-committees/… |
| Occupational Exposure Assessment of a-Pinene and related Monoterpenes |
Research Initiative |
CDC, FDA |
NIEHS |
This research will define the range of exposures present across several industries that routinely handle monoterpene compounds, to determine which working populations are most at risk of elevated exposures to monoterpenes. |
| Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS) |
Research Initiative |
CDC |
NIEHS |
The primary objectives of this study are to identify PFAS compounds currently in use in commerce or industry and the companies, industries, and worker populations who are manufacturing, processing, or using PFAS products and to conduct targeted occupational exposure assessments in high- and moderate-PFAS volume industries. Based on the results of the exposure assessment, secondary objectives of this study are to assess health effects associated with PFAS exposure. |
| ODP Prevention Scientific Interest Groups (SIGs) |
Committee, Work group, Advisory group, or Task Force |
AHRQ, CDC, FDA, OASH |
NCI, NHLBI, NICHD, NIDDK, NIEHS, NIMHD, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP |
The Office of Disease Prevention (ODP) Prevention Scientific Interest Groups (SIGs) develop collaborative research initiatives to address unmet prevention research needs. To avoid overlap with other collaborative research planning groups, they focus on areas where there are no existing collaborative NIH-wide or federal groups. |